Market cap
$1.01B

CryoPort Inc. (CYRX) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 6 wire items for CYRX, including 2 earnings updates, 2 SEC filings and 2 insider trades. The most recent was published Nov 12, 2026.

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities are maintained throughout the shipping cycle; and Cryoport Express Advanced Therapy Shippers that provides verification processes to biopharma companies. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

CYRX rankings

Financial highlights

Full financials
Revenue, TTM
$192.44M
Revenue growth
+11.8%
Net income, TTM
-$41.30M
Net margin
-21.5%
Free cash flow, TTM
-$18.81M
Cash
$279.18M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks23+400%
2026-05-24: 12026-05-31: 02026-06-07: 72026-06-14: 02026-06-21: 32026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 12026-07-26: 02026-08-02: 32026-08-09: 22026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 12026-10-25: 02026-11-01: 32026-11-08: 22026-11-15: 0
2026-05-242026-11-15
Mix690d
  • Earnings2(33%)
  • SEC Filings2(33%)
  • Insider2(33%)
Activity · 52 weeks4829 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

CYRX FAQ

10 questions
  • What does CryoPort Inc. do?
    Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities are...
  • What is the latest news on CYRX?
    In the last 30 days Quantisnow tracked 6 wire items for CYRX: 2 earnings updates, 2 SEC filings and 2 insider trades. The most recent was published on November 12, 2026.
  • What is CYRX revenue?
    CryoPort Inc. (CYRX) reported $192.44M of revenue for the twelve months ended Sep 30, 2026. That is up 11.8% from the year before. Revenue for fiscal 2025 was $176.18M.
  • Is CYRX profitable?
    No. CryoPort Inc. reported a net loss of $41.30M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does CYRX have?
    CryoPort Inc. reported $279.18M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does CYRX stock trade?
    CryoPort Inc. (CYRX) is listed on NASDAQ.
  • What sector and industry is CYRX in?
    CryoPort Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • What are analysts saying about CYRX?
    Across the last 8 analyst actions on CryoPort Inc., there were 4 upgrades and 1 downgrade. The most recent action was from KeyBanc Capital Markets: Overweight on 2025-08-06. Recent price targets range from $8.00 to $16.00.
  • What companies are similar to CYRX?
    Notable peers in the same industry include MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories). Compare CYRX side-by-side with any of them on Quantisnow.
  • How can I track CYRX on Quantisnow?
    Quantisnow aggregates CryoPort Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CYRX to receive live email and push alerts on every new disclosure.